CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-23 | RASTETTER WILLIAM H Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2022-06-23 | Steele Robin Joan Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2022-06-23 | Matz Gregory W Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2022-06-23 | Ononye-Onyia Sophia Nnenna Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2022-06-23 | Grossman Jessica D. Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2022-06-23 | Blanchard Cheryl R Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2022-06-23 | Kelley Susan L. Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2022-01-25 | Fair John A Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2022-01-25 | JOHNSON SABRINA MARTUCCI Chef Executive Officer | Grant or award · Stock Option (right to buy) | +628,400 | 628,400 | ||
| 2022-01-25 | Walters-Hoffert Lisa Chief Financial Officer | Grant or award · Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2021-06-24 | Steele Robin Joan Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-06-24 | Matz Gregory W Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-06-24 | Kelley Susan L. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-06-24 | Blanchard Cheryl R Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-06-24 | Grossman Jessica D. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-06-24 | RASTETTER WILLIAM H Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-04-16 | Ononye-Onyia Sophia Nnenna Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2021-01-26 | Fair John A Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +168,000 | 168,000 | ||
| 2021-01-26 | Walters-Hoffert Lisa Chief Financial Officer | Grant or award · Stock Option (right to buy) | +168,000 | 168,000 | ||
| 2021-01-26 | JOHNSON SABRINA MARTUCCI Chef Executive Officer | Grant or award · Stock Option (right to buy) | +525,000 | 525,000 |
Page 3 of 18 · 344 trades